Monocyte chemoattractant protein inhibits the generation of tumor- reactive T cells

Cancer Research

Volumn 57, Issue 21, 1997, Pages 4849-4854

  Peng, Liaomin ^a   Shu, Suyu ^a   Krauss, John C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MONOCYTE CHEMOTACTIC PROTEIN; TUMOR ANTIGEN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SARCOMA; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES; CARCINOGENS; CHEMOKINE CCL2; FEMALE; IMMUNOTHERAPY, ADOPTIVE; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; SARCOMA, EXPERIMENTAL; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 0030780374     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Rosenberg, S. A. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J. Natl. Cancer Inst., 88: 1635-1644, 1996.
2. Shu, S., Strome, S. E., Krauss, J. C., Plautz, G. E., and Chang, A. E. Tumor-draining lymph nodes as a source for generating therapeutic immune T cells. In: A. E. Chang and S. Shu (eds.), Immunotherapy of Cancer with Sensitized T Lymphocytes, pp. 1-11. Austin, TX: R. G. Landes Company, 1994.
3. Chang, A. E., Aruga, A., Cameron, M. J., Sondak, V. K., Normolle, D. P., Fox, B. A., and Shu, S. Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. J. Clin. Oncol., 15: 796-807, 1997.
4. Rosenberg, S. A., Yannelli, J. R., Yang, J. C., Topalian, S. L., Schwartzentruber, D. J., Weber, J. S., Parkinson, D. R., Seipp, C. A., Einhorn, J. H., and White, D. E. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2. J. Natl. Cancer Inst., 86: 1159-1166, 1994.
5. Yoshizawa, H., Sakai, K., Chang, A. E., and Shu, S. Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapy. Cell. Immunol., 134: 473-479, 1991.
6. Krauss, J. C., Stein, J. M., and Shu, S. Tumor reactivity of immune T cells in short-term culture. Cancer Immunol. Immunother., 43: 231-239, 1996.
7. Arca, M. J., Krauss, J. C., Aruga, A., Cameron, M. J., Shu, S., and Chang, A. E. Therapeutic efficacy of T cells derived from lymph nodes draining a poorly immunogenic tumor transduced to secrete granulocyte-macrophage colony-stimulating factor. Cancer Gene Ther., 3: 39-47, 1996.
8. Mantovani, A. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Invest., 71: 5-16, 1994.
9. Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265-270, 1992.
10. Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., and Mantovani, A. Regulation of the macrophage content of neoplasms by chemoattractants. Science (Washington DC), 220: 210-212, 1982.
11. Bottazzi, B., Erba, E., Nobili, N., Fazioli, F., Rambaldi, A., and Mantovani, A. A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. J. Immunol., 144: 2409-2412, 1990.
12. Negus, R. P. M., Stamp, G. W. H., Relf, M. G., Burke, F., Malik, S. T. A., Bernasconi, S., Allavena, P., Sozzani, S., Mantovani, A., and Balkwill, F. R. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest., 95: 2391-2395, 1995.
13. Van Damme, J., Proost, P., Lenaerts, J. P., and Opdenakker, G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med., 176:: 59-65, 1992.
14. Oguccioni, M., Loetscher, P., Forssmann, U., Dewald, B., Li, H., Lima, S. H., Li, Y., Kreider, B., Garotta, G., Thelen, M., and Baggiolini, M. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med., 183: 2379-2384. 1996.
15. Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., Kuratsu, J. I., and Leonard, E. J. Purification and amino acid analysis of two human glioma-denved monocyte chemoattractants. J. Exp. Med., 169: 1449-1459, 1989.
16. Roth, S. J., Carr, M. W., and Springer, T. A. C-C chemokines, but not the C-X-C chemokines interleukin 8 and interferon-gamma inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur. J. Immunol., 25: 3482-3488, 1995.
17. Yoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., and Leonard, E. J. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett., 244: 487-493, 1989.
18. Cochran, B. H., Reffel, A. C., and Stiles, C. D. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell, 33: 939-947, 1983.
19. Oppenheim, J. J., Zachariae, C. O., Mukaida, N., and Matsushima, K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol., 9: 617-648, 1991.
20. Ho, M. K., and Springer, T. A. Mac-1 antigen quantitative expression in macrophage populations and tissues, and immunofluorescent localization in spleen. J. Immunol., 128: 2281-2286, 1982.
21. Metlay, J. P., Witmer-Pack, M. G., Agger, R., Crowley, M. T., Lawless, D., and Stemman, R. M. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J. Exp. Med., 171: 1753-1771, 1990.
22. Dialynas, D. P., Quan, Z. S., Wall, K. A., Pierres, A., Quintans, J., Loken, M. R., Pierres, M., and Fitch, F. W. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol., 131: 2445-2451, 1983.
23. Sarmiento, M., Glasebrook, A. L., and Fitch, F. W. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement. J. Immunol., 125: 2665-2672, 1980.
24. Austyn, J. M., and Gordon, S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol., 11: 805-815, 1981.
25. Chensue, S. W., Warmington, K. S., Ruth, J. H., Sanghi, P. S., Lincoln, P., and Kunkel, S. L. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation. J. Immunol., 157: 4602-4608, 1996.
26. Leo, O., Foo, M., Sachs, D. H., Samelson, L. E., and Bluestone, J. A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA, 84: 1374-1378, 1987.
27. Plautz, G. E., Inoue, M., and Shu, S. Defining the synergistic effects of irradiation and T-cell immunotherapy for murine intracranial tumors. Cell. Immunol., 171: 277-284, 1996.
28. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H. Role of bone marrow-derived cells in presenting MHC class 1-restricted tumor antigens. Science (Washington DC), 264: 961-965, 1994.
29. Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., and Schuler, G. Proliferating dendritic cell progenitors in human blood. J. Exp. Med., 180: 83-93, 1994.
30. Sozzani, S., Sallusto, F., Luini, W., Zhou, D., Piemonti, L., Allavena, P., Van Damme, J., Valitutti, S., Lanzavecchia, A., and Mantovani, A. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol., 155: 3292-3295, 1995.
31. Takeshima, H., Kuratsu, J. I., Takeya, M., Yoshimura, T., and Ushio, Y. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J. Neurosurg., 80: 1056-1062, 1994.
32. Walter, S., Bottazzi, B., Govoni, D., Colotta, F., and Mantovani, A. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE, Int. J. Cancer, 49: 431-435, 1991.
33. Huang, S., Singh, R. K., Xie, K., Gutman, M., Berry, K. K., Bucana, C. D., Fidler, I. J., and Bar-Eli, M. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol. Immunother., 39: 231-238, 1994.
34. Huffnagle, G. B., Strieter, R. M., Standiford, T. J., McDonald, R. A., Burdick, M. D., Kunkel, S. L., and Toews, G. B. The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary cryptococcus neoformans infection. J. Immunol., 155: 4790-4797, 1995.
35. Chensue, S. W., Warmington, K. S., Lukacs, N. W., Lincoln, P. M., Burdick, M. D., Strieter, R. M., and Kunkel, S. L. Monocyte chemotactic protein expression during schistosome egg granuloma formation. Am. J. Pathol., 146: 130-138, 1995.
36. Rutledge, B. J., Rayburn, H., Rosenberg, R., North, R. J., Gladue, R. P., Corless, C. L., and Rollins, B. J. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol., 155: 4838-4843, 1995.
37. Vaddi, K., and Newton, R. C. Regulation of monocyte integrin expression by β-family chemokines. J. Immunol., 153: 4721-4732, 1994.